Trade

with

Masimo Corp
(NASDAQ: MASI)
AdChoices
22.22
+0.45
+2.07%
After Hours :
-
-
-

Open

21.92

Previous Close

21.77

Volume (Avg)

406.83k (615.94k)

Day's Range

21.59-22.24

52Wk Range

19.30-32.20

Market Cap.

1.22B

Dividend Rate ( Yield )

-

Beta

0.77

Shares Outstanding

54.77M

P/E Ratio (EPS)

20.79 (1.07)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 547.24M

    • Net Income

    • 58.38M

    • Market Cap.

    • 1.22B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 11.06

    • PEG (Price/Earnings Growth) Ratio

    • 0.80

    • Beta

    • 0.77

    • Forward P/E

    • 16.34

    • Price/Sales

    • 2.30

    • Price/Book Value

    • 3.81

    • Price/Cash flow

    • 20.49

      • EBITDA

      • 91.14M

      • Return on Capital %

      • 13.69

      • Return on Equity %

      • 20.02

      • Return on Assets %

      • 13.69

      • Book Value/Share

      • 5.83

      • Shares Outstanding

      • 54.77M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 29.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 1.36

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 2.50

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -6.20

          • -22.64

          • Net Income

            Q/Q (last year)

          • -19.00

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 12.25

          • 4.60

          • Net Income

            5-Year Annual Average

          • 12.80

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 65.52

            • 64.08

            • Pre-Tax Margin

            • 14.62

            • 15.19

            • Net Profit Margin

            • 11.06

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 68.10

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 20.10

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • 14.20

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.34

              • Current Ratio

              • 1.59

              • 2.55

              • Quick Ratio

              • 1.05

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.56

              • 1.86

              • Book Value/Share

              • 5.83

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 20.28

                • 34.48

                • P/E Ratio 5-Year High

                • 32.87

                • 224.03

                • P/E Ratio 5-Year Low

                • 16.48

                • 60.23

                • Price/Sales Ratio

                • 2.25

                • 3.20

                • Price/Book Value

                • 3.72

                • 3.23

                • Price/Cash Flow Ratio

                • 20.49

                • 18.66

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 20.02

                    (23.40)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 13.69

                    (17.70)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 17.82

                    (23.30)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 19.54k

                  • 34.11k

                  • Inventory Turnover

                  • 3.35

                  • 2.77

                  • Asset Turnover

                  • 1.24

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  79.72M
                  Operating Margin
                  14.57
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  20.49
                  Ownership

                  Institutional Ownership

                  78.77%

                  Top 10 Institutions

                  37.00%

                  Mutual Fund Ownership

                  51.26%

                  Float

                  79.83%

                  5% / Insider Ownership

                  4.26%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Janus Triton Fund

                  •  

                    2,006,774

                  • -5.46

                  • 3.66

                  • Champlain - Small Cap Equity

                  •  

                    1,663,660

                  • -1.92

                  • 3.04

                  • Janus Enterprise Fd

                  •  

                    1,274,076

                  • 0.00

                  • 2.33

                  • Janus Venture Fund

                  •  

                    1,055,475

                  • 0.00

                  • 1.93

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    1,007,514

                  • 0.57

                  • 1.88

                  • Vanguard Small Cap Index

                  •  

                    856,397

                  • -3.79

                  • 1.56

                  • Fidelity® Value Fund

                  •  

                    855,600

                  • -31.09

                  • 1.56

                  • Vanguard Total Stock Mkt Idx

                  •  

                    832,170

                  • 0.21

                  • 1.52

                  • Fidelity® Select Health Care Portfolio

                  •  

                    800,000

                  • -27.27

                  • 1.46

                  • Undiscovered Managers Behavioral Value

                  •  

                    739,500

                  • 17.21

                  • 1.35

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Janus Capital Management LLC

                  •  

                    5,340,626

                  • -3.61%

                  • 9.75

                  • Vanguard Group, Inc.

                  •  

                    3,355,031

                  • +5.37%

                  • 6.13

                  • BlackRock Fund Advisors

                  •  

                    2,761,173

                  • +15.46%

                  • 5.04

                  • Champlain Investment Partners, LLC

                  •  

                    1,826,415

                  • -19.63%

                  • 3.33

                  • Camber Capital Management LLC

                  •  

                    1,820,000

                  • +42.75%

                  • 3.32

                  • Fidelity Management and Research Company

                  •  

                    1,131,755

                  • -80.16%

                  • 2.07

                  • ING Investment Management LLC

                  •  

                    1,035,384

                  • -2.49%

                  • 1.89

                  • Westfield Capital Management Company, LP

                  •  

                    1,033,030

                  • -25.16%

                  • 1.89

                  • State Street Corp

                  •  

                    983,081

                  • -38.36%

                  • 1.79

                  • Fuller & Thaler Asset Management, Inc.

                  •  

                    978,000

                  • +36.80%

                  • 1.79

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Slow Growth

                  Style

                  Small Growth

                  Masimo Corp was incorporated in California in May 1989 and reincorporated in Delaware in May 1996. The Company is a medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies....more Its core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, known as Masimo SET pulse oximetry, but our product offerings have expanded significantly over the years to also include noninvasive blood constituent, brain and breath monitoring, including rainbow Pulse CO-Oximetry, brain function electroencephalogram (EEG) monitoring, respiration rate, capnography and anesthetic agent monitoring. In addition, they have developed the Root patient monitoring and connectivity platform and Patient SafetyNet remote pat...moreient surveillance monitoring system. They provide their products directly and through distributors and OEM partners to hospitals, emergency medical service (EMS) providers, physician offices, veterinarians, long term care facilities and consumers. The Company sell their products to end-users through its direct sales force and certain distributors, as well as its OEM partners, for incorporation into their products. They also offer a patient surveillance or remote monitoring and clinician notification solution called Patient SafetyNet, which includes Masimo SET or rainbow SET platform measurements at the patient’s bedside along with a central assignment station and wired or wireless server. In October 2012, they received both FDA clearance for uSpO2, a universal “Board-in-Cable” pulse oximetry solution, enabling easier and faster integration for OEM partners due to the ability to integrate Masimo SET through software only. The Company acquired Spire Semiconductor, LLC, a maker of advanced light emitting diode and other advanced component-level technologies. Masimo Semiconductor, Inc. (Masimo Semiconductor), its wholly owned subsidiary, operates this business and specializes in wafer epitaxy, foundry services, and device fabrication for biomedical, telecommunications, consumer products and other markets. The Company offer Masimo SET and rainbow SET through its OEMs for integration in their products and through its own end-user products, including the Root, Radical-7, Rad-87, Rad-57, Pronto-7, Pronto, Rad-8, Rad-5 and Rad-5v. The Company has 674 issued and pending patents worldwide. They have licensed from Cercacor Laboratories, Inc. (Cercacor), the right to OEM selected rainbow technology and to incorporate selected rainbow technology into their products intended to be used by professional caregivers, including, but not limited to, hospital caregivers and alternate care facility caregivers. The Company is subject to U.S. Food, Drug, and Cosmetic Act (FDCA) and the regulations promulgated under that Act, the FDA regulates the design, development, clinical trials, testing, manufacture, packaging, labeling, storage, distribution and promotion of medical devices.lessless

                  Key People

                  Mr. Joe E. Kiani

                  CEO/Chairman of the Board/Director/Founder

                  Mark P. De Raad

                  CFO/Chief Accounting Officer/Executive VP/Secretary

                  Yongsam Lee

                  Chief Information Officer

                  Anand Sampath

                  COO, Divisional/Executive VP, Divisional

                  Paul Jansen

                  Executive VP, Divisional

                  • Masimo Corp

                  • 40 Parker

                  • Irvine, 92618

                  • USA.Map

                  • Phone: +1 949 297-7000

                  • Fax: +1 949 297-7001

                  • masimo.com

                  Incorporated

                  1989

                  Employees

                  3,139

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: